Jiang L - Search Results

1

PKG II effectively reversed EGF-induced protein expression alterations in human gastric cancer cell lines.

Qian H, Tao Y, Jiang L, Wang Y, Lan T, Wu M, Pang J, Appiah-Kubi K, Chen Y, Wu Y. Qian H, et al. Among authors: jiang l. Cell Biol Int. 2018 Apr;42(4):435-442. doi: 10.1002/cbin.10912. Epub 2017 Dec 14. Cell Biol Int. 2018. PMID: 29150923

2

Type II cGMP-dependent protein kinase inhibits EGF-induced MAPK/JNK signal transduction in breast cancer cells.

Lan T, Chen Y, Sang J, Wu Y, Wang Y, Jiang L, Tao Y. Lan T, et al. Among authors: jiang l. Oncol Rep. 2012 Jun;27(6):2039-44. doi: 10.3892/or.2012.1726. Epub 2012 Mar 15. Oncol Rep. 2012. PMID: 22427012

3

PKG II inhibits EGF/EGFR-induced migration of gastric cancer cells.

Jiang L, Lan T, Chen Y, Sang J, Li Y, Wu M, Tao Y, Wang Y, Qian H, Gu L. Jiang L, et al. PLoS One. 2013 Apr 16;8(4):e61674. doi: 10.1371/journal.pone.0061674. Print 2013. PLoS One. 2013. PMID: 23613900 Free PMC article.

4

Type II cGMP-dependent protein kinase inhibits ligand‑induced activation of EGFR in gastric cancer cells.

Jiang L, Chen Y, Li Y, Lan T, Wu M, Wang Y, Qian H. Jiang L, et al. Mol Med Rep. 2014 Apr;9(4):1405-9. doi: 10.3892/mmr.2014.1942. Epub 2014 Feb 10. Mol Med Rep. 2014. PMID: 24534906

5

PKG II reverses HGF-triggered cellular activities by phosphorylating serine 985 of c-Met in gastric cancer cells.

Wu Y, Yao X, Zhu M, Qian H, Jiang L, Lan T, Wu M, Pang J, Chen Y. Wu Y, et al. Among authors: jiang l. Oncotarget. 2016 Jun 7;7(23):34190-200. doi: 10.18632/oncotarget.9074. Oncotarget. 2016. PMID: 27147579 Free PMC article.

6

Type II cGMP‑dependent protein kinase inhibits EGF‑induced JAK/STAT signaling in gastric cancer cells.

Wu M, Wu Y, Lan T, Jiang L, Qian H, Chen Y. Wu M, et al. Among authors: jiang l. Mol Med Rep. 2016 Aug;14(2):1849-56. doi: 10.3892/mmr.2016.5452. Epub 2016 Jun 27. Mol Med Rep. 2016. PMID: 27357186

7

Protein Kinases Type II (PKG II) Combined with L-Arginine Significantly Ameliorated Xenograft Tumor Development: Is L-Arginine a Potential Alternative in PKG II Activation?

Wu Y, Liu Y, Cai Z, Qin H, Li H, Su W, Wang Y, Qian H, Jiang L, Wu M, Pang J, Chen Y. Wu Y, et al. Among authors: jiang l. Med Sci Monit. 2018 Feb 5;24:736-742. doi: 10.12659/msm.906213. Med Sci Monit. 2018. PMID: 29401205 Free PMC article.

8

The constitutively active PKG II mutant effectively inhibits gastric cancer development via a blockade of EGF/EGFR-associated signalling cascades.

Wu Y, Yuan M, Su W, Zhu M, Yao X, Wang Y, Qian H, Jiang L, Tao Y, Wu M, Pang J, Chen Y. Wu Y, et al. Among authors: jiang l. Ther Adv Med Oncol. 2018 Feb 1;10:1758834017751635. doi: 10.1177/1758834017751635. eCollection 2018. Ther Adv Med Oncol. 2018. PMID: 29434677 Free PMC article.

9

PKG II inhibits PDGF-BB triggered biological activities by phosphorylating PDGFRβ in gastric cancer cells.

Wang Y, Appiah-Kubi K, Lan T, Wu M, Pang J, Qian H, Tao Y, Jiang L, Wu Y, Chen Y. Wang Y, et al. Among authors: jiang l. Cell Biol Int. 2018 Sep;42(10):1358-1369. doi: 10.1002/cbin.11020. Epub 2018 Jul 4. Cell Biol Int. 2018. PMID: 29935031

10

LPS-induced nuclear translocation of RhoA is dependent on NF-κB in the human lung cancer cell line A549.

Tao Y, Chen YC, Lan T, Qian H, Wang Y, Jiang L. Tao Y, et al. Among authors: jiang l. Oncol Lett. 2012 Jun;3(6):1283-1287. doi: 10.3892/ol.2012.667. Epub 2012 Apr 2. Oncol Lett. 2012. PMID: 22783434 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

24,678 results

Search Page

Filters